Literature DB >> 17854365

Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.

S Antinori1, E Longhi, G Bestetti, R Piolini, V Acquaviva, A Foschi, S Trovati, C Parravicini, M Corbellino, L Meroni.   

Abstract

Post-kala-azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis (VL) observed mainly in Sudan and India where it follows treated VL in 50% and 10% of cases, respectively. We report a 46-year-old patient with acquired immune deficiency syndrome who, 7 months after diagnosis of VL, developed PKDL and uveal leishmaniasis following HAART-induced immune recovery. In southern Europe PKDL seems to be an emerging clinical presentation among human immunodeficiency virus (HIV)-infected patients experiencing HAART-induced immune recovery after a previous diagnosis of VL. The best treatment among HIV-infected patients remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854365     DOI: 10.1111/j.1365-2133.2007.08157.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  17 in total

1.  Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia.

Authors:  Tesfaye Gelanew; Zewdu Hurissa; Ermias Diro; Aysheshm Kassahun; Katrin Kuhls; Gabriele Schönian; Asrat Hailu
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

Review 2.  Leishmaniasis as a Manifestation of Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV-Infected Patients: A Literature Review.

Authors:  Roberto Badaró; Larissa O Gonçalves; Luana L Gois; Zuinara Pereira Gusmão Maia; Constance Benson; Maria Fernanda Rios Grassi
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-10-20

Review 3.  The immune reconstitution inflammatory syndrome related to HIV co-infections: a review.

Authors:  D Huis in 't Veld; H-Y Sun; C-C Hung; R Colebunders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

4.  Molecular characterization of Leishamania isolates from China by inter-simple sequence repeat polymerase chain reaction.

Authors:  Yong Wang; Yuetao Yang; Junyun Wang; Yifang Bao; Liren Guan; Chunhua Gao; Feng Shi
Journal:  Parasitol Res       Date:  2010-03-17       Impact factor: 2.289

Review 5.  Leishmaniasis: clinical syndromes and treatment.

Authors:  B S McGwire; A R Satoskar
Journal:  QJM       Date:  2013-06-05

Review 6.  Leishmaniasis: new insights from an old and neglected disease.

Authors:  S Antinori; L Schifanella; M Corbellino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

7.  Immune reconstitution inflammatory syndrome: incidence and implications for mortality.

Authors:  Richard M Novak; James T Richardson; Kate Buchacz; Joan S Chmiel; Marcus D Durham; Frank J Palella; Andrea Wendrow; Kathy Wood; Benjamin Young; John T Brooks
Journal:  AIDS       Date:  2012-03-27       Impact factor: 4.177

Review 8.  Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges.

Authors:  Veeranoot Nissapatorn; Nongyao Sawangjaroen
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

9.  Post-kala-azar dermal Leishmaniasis in two different clinical contexts.

Authors:  Daniel Holanda Barroso; Claúdia Elise Ferraz Silva; Ana Carolina Depes Perdigao e Vasconcelos; Silvana Maria de Morais Cavalcanti; Maria Edileuza Felinto de Brito; Angela Cristina Rapela Medeiros
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

10.  Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients.

Authors:  Eltahir Awad Gasim Khalil; Selma Abdelmoneim Khidir; Ahmed Mudawi Musa; Brema Younis Musa; Mona Elfaki Eltahir Elfaki; Abdelgadir Mohamed Yousif Elkadaru; Edward Zijlstra; Ahmed Mohamed El-Hassan
Journal:  J Trop Med       Date:  2013-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.